Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
PurposeTo assess the acceptability and feasibility of the Phoenix smoking cessation smartphone app in people who smoke and are not yet ready to quit.Approach/DesignPost-intervention telephone interview.SettingOklahoma and Texas.ParticipantsAdults who were not ready to quit smoking at baseline (71% female, 76% White, mean age 52.6 years).InterventionThis 26-week 3-arm randomized controlled trial examined the utility of the Phoenix app which encouraged and provided support for smoking cessation attempts through twice-daily messages and weekly surveys.MethodsParticipants (100/152) completed an audio-recorded interview that assessed app engagement including benefits, barriers, most useful features, and suggested app modifications. Transcribed interviews were coded and analyzed for themes.ResultsAdults who were not ready to quit smoking experienced few barriers to using Phoenix app content, and reported increased self-reflection, awareness of smoking behaviors, and motivation to quit smoking in response to the tailored messages and weekly assessments. Participants with less control over daily schedules wanted more access to missed messages and surveys. Messages and surveys were helpful, but participants suggested increasing the variety of message and survey content.ConclusionAdults not yet ready to quit smoking are receptive to using mHealth smoking cessation apps to reduce/quit smoking. mHealth applications can increase access to evidence-based smoking cessation interventions and may be an effective tool for reducing smoking disparities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/08901171251361470 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening.
Cancer
September 2025
Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Tobacco use is the primary contributor to disease and death in the United States, and cigarette smoking is the leading risk factor for lung cancer. Safe and effective treatments for tobacco dependence exist; however, access to and use of tobacco treatment remains low. The most recent Centers for Medicare and Medicaid Services National Coverage Determination requires a shared decision-making visit for lung cancer screening that includes counseling on the importance of maintaining cigarette smoking abstinence if a person formerly smoked; or the importance of smoking cessation if a person currently smokes and, if appropriate, furnishing of information about tobacco-cessation interventions.
View Article and Find Full Text PDFImmediate and durable effects of maternal tobacco consumption on placental DNA methylation: a replication and discovery study.
Environ Epigenet
May 2025
Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institut pour l'Avancée des Biosciences (IAB), Team of Environmental Epidemiology Applied to Development and Respiratory Health, 38000 Grenoble, France.
An increasing number of epigenome-wide association studies report tobacco smoking-associated DNA methylation levels. However, comprehensive replication studies remain scarce, particularly in placenta, despite their crucial interest in such a large-scale context. Using DNA methylation data from the EPIC array of 341 new placentas (85 smokers, 219 non-smokers, and 37 former smokers) from the EDEN cohort, we used a candidate approach to replicate maternal smoking-associated CpGs and regions previously identified using the 450K array, and an exploratory approach to discover new associations within EPIC-specific CpGs.
View Article and Find Full Text PDFAssociation between changes in secondhand smoke exposure and incident metabolic syndrome among Korean former smokers.
Nutr Metab Cardiovasc Dis
August 2025
Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Background And Aims: Although secondhand smoke (SHS) exposure has been linked with metabolic syndrome (MetS) in never-smokers, its effects among individuals who have quit smoking remain unclear. This study investigated the relationship between changes in SHS exposure and incident MetS in a large cohort of Korean former smokers.
Methods And Results: We analyzed 17,269 Korean former smokers without MetS at baseline from a longitudinal cohort, with a median follow-up of three years.
Investigating the substitutability of little cigars/cigarillos, e-cigarettes, and other noncombusted tobacco products for cigarettes using the experimental tobacco marketplace.
Exp Clin Psychopharmacol
September 2025
Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont.
The U.S. Food and Drug Administration has proposed a nicotine-limiting standard, which would increase the unit price of nicotine in cigarettes and could cause people who smoke and are unable/unwilling to quit nicotine to switch to other products.
View Article and Find Full Text PDFRural and Appalachian cancer survivors' responses to tobacco use screening and tobacco treatment offer.
Tob Induc Dis
September 2025
Department of Psychology, College of Arts and Sciences, University of Kentucky, Lexington, United States.
Introduction: Smoking after a cancer diagnosis is associated with poor outcomes whereas smoking cessation improves survival and other outcomes. Although professional societies and practice guidelines call for equitable tobacco treatment delivery in healthcare, disparities in tobacco-related disease burden persist.
Methods: In the context of an outpatient US cancer center's population-based tobacco treatment program, this study examines associations between cancer survivors' rural and Appalachian residence status and: 1) current tobacco use status, 2) decision to decline tobacco treatment, and 3) reason for declining assistance.